Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 21, 11:40
2708.00
32.4 (1.21%)
VOLUME 1,490
LIVE
NSE
Nov 21, 11:42
2710.00
34.45 (1.29%)
VOLUME 14,164
Announcements on AstraZeneca

30th-Oct-2019 15:41Source: BSE

AstraZeneca Pharma- Intimation Regarding Chairmanship Of Stakeholders' Relationship Committee

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform that Ms. Revathy Ashok (DIN: 00057539), Non-Executive Independent Director, has ...

25th-Oct-2019 17:32Source: BSE

AstraZeneca Pharma- Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on October 25, 2019 in respect...

24th-Oct-2019 17:20Source: BSE

AstraZeneca Pharma- Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, November 11, 2019

ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve the Unaudited Financial Results ...

21st-Oct-2019 18:20Source: BSE

AstraZeneca Pharma- Launch Of Durvalumab (Imfinzi) In India

We refer to our communication dated June 21, 2018 with regard to the receipt of Import and Market Permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India for durvalu...

25th-Sep-2019 18:00Source: BSE

AstraZeneca Pharma- Astrazeneca Pharma India Limited Receives Import And Market Permission In Form 45 (Marketing Authorization) From Drugs Controller General Of India (DCGI) For FDC Of Dapagliflozin 10Mg + Saxagliptin 5Mg Film Coated Tablets (QTERN

This is to inform that AstraZeneca Pharma India Limited has received Import and Market permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India for FDC of Dapaglifloz...

25th-Sep-2019 18:00Source: BSE

AstraZeneca Pharma- Astrazeneca Pharma India Limited Receives Import And Market Permission In Form 45 (Marketing Authorization) From Drugs Controller General Of India (DCGI) For FDC Of Dapagliflozin 10Mg + Saxagliptin 5Mg Film Coated Tablets (QTERN

This is to inform that AstraZeneca Pharma India Limited has received Import and Market permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India for FDC of Dapaglifloz...

9th-Aug-2019 17:53Source: BSE

AstraZeneca Pharma- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate as per atta...

7th-Aug-2019 19:59Source: BSE

AstraZeneca Pharma- Announcement under Regulation 30 (LODR)-Date of payment of Dividend

We would wish to inform that at the Board Meeting of the Company held today i.e., on August 7, 2019, the Board of Directors have inter-alia declared an Interim Dividend of Rs. 1.00 per equity share. ...

1st-Aug-2019 18:22Source: BSE

AstraZeneca Pharma- Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on August 1, 2019 in respect o...

29th-Jul-2019 18:19Source: BSE

AstraZeneca Pharma- Board to consider Interim Dividend

AstraZeneca Pharma India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 07, 2019, inter alia, to:1. consider and approve the Unaudited Financial Re...

1 2 3 4 5 Next >>
Quick Links for AstraZeneca Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.